Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00005016 · ClinicalTrials.gov registry record

Study of the Experiences and Needs of Parents Continuing a Pregnancy Following a Prenatal Diagnosis of Holopresencephaly

A clinical trial of Holoprosencephaly, sponsored by National Human Genome Research Institute (NHGRI).

Completed
Registry status
30
Enrollment target
1
Study location

NCT00005016: Completed study of Holoprosencephaly, sponsored by National Human Genome Research Institute (NHGRI).

NCT00005016 is a study of Holoprosencephaly that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00005016, a study of Holoprosencephaly, has completed, sponsored by National Human Genome Research Institute (NHGRI).

COMPLETED
Registry status
30 participants
Enrollment target
1
Study location

Study Summary

This study will examine the experiences of parents who decided to continue a pregnancy after receiving a prenatal diagnosis of holopresencephaly (HPE). HPE results from a genetic defect that can cause facial abnormalities such as cleft lip and cleft palate, learning disabilities, muscle weakness, problems with digestion, sleep and muscle control, and other disabilities. The severity of symptoms varies greatly among affected children. Parents whose child was diagnosed before birth with HPE may be eligible for this study. It involves a one-time interview that takes from about 45 to 60 minutes. The interview is conducted either in person or by telephone and consists of three parts, as follows: 1. The experience of receiving the diagnosis of HPE during the pregnancy \< includes general questions such as when and how HPE was diagnosed, what kind of information the parent received, the parent's reaction to the diagnosis, what genetic counseling, if any, the parents received, and so forth. 2. Emotional and informational needs \< includes questions about the parent's specific emotional and informational needs from the time of diagnosis until the baby's birth, and the parent's reactions to support that was given. 3. Questionnaire \< includes questions about the parent and his or her child, such as the parent's age, gender, marital status, and religious background, the child's age, gender, medical problems, and so forth. The questionnaire will be completed verbally for telephone interviews and in writing for in-person interviews. The interview will be tape-recorded and will be kept confidential. Information from this study will provide health professionals, including genetic counselors, more effective strategies for helping other parents who face similar prenatal diagnoses.

Conditions Studied

Study Locations (1)

Maryland

  • National Human Genome Research Institute (NHGRI) - Bethesda

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2000-03
Est. Completion 2001-02

What the finished NCT00005016 record still lists

NCT00005016 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.

The record links to 1 condition, with Holoprosencephaly appearing as the primary indexed condition, and to 0 interventions.

NCT00005016 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT00005016 about?

NCT00005016 is a clinical study titled "Study of the Experiences and Needs of Parents Continuing a Pregnancy Following a Prenatal Diagnosis of Holopresencephaly". This study will examine the experiences of parents who decided to continue a pregnancy after receiving a prenatal diagnosis of holopresencephaly (HPE). HPE results from a genetic defect that can cause facial abnormalities such as cleft lip and cleft palate, learning disabilities, muscle weakness, pr...

What is the current status of trial NCT00005016?

This trial is currently completed. The enrollment target is 30 participants. The study started on 2000-03. Estimated completion is 2001-02.

What conditions does trial NCT00005016 study?

This clinical trial studies the following conditions: Holoprosencephaly.

Who is sponsoring clinical trial NCT00005016?

This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00005016 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Holoprosencephaly

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00005016, the US trial registry maintained by the National Library of Medicine. NCT00005016 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.